The Difference Full Service RTSM Can Make for Study Managers

By Marc Weinberg, MBA, Director of RTSM

The cost of clinical trials continues to rise as studies grow in complexity. In fact, a recent clinical trial for a rare hereditary metabolic disorder that enrolled only 4 patients reportedly cost a total of $2.1 million ^[1]. The rising complexity (and corresponding costs) of randomized trials stems from a variety of factors that complicate supply management, including:

• Complex protocols
• Shorter timelines for patient enrollment
• Country-specific regulations
• Lack of historical data to create accurate forecasts
• Logistical challenges in transporting and distributing trial drugs and IP
• Cross-system alignment

In this article, we’ll explore how a full-service Randomization and Trial Supply Management (RTSM) solution, the next evolution of technologies like Interactive Response System (IRT),  can maximize efficiencies for study managers and their teams.